Single-Use-Systems: Leachable Study Design for Single-Use Components
Posted on February 21, 2018
Kathryn McGohan
Scientist I
Bristol-Myers Squibb
Biopharmaceutical manufacturers can realize substantial gains in process flexibility, speed, and efficiency through implementation of polymeric single-use systems (SUS) for use in their manufacturing processes. The use of polymeric single-use-systems (SUS) and components has increased dramatically i...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
antioxidants, biopharmaceutical manufacturing process, blocking agents, Bristol-Myers Squibb, bulk drug substance, Kathryn McGohan, Leachable Study Design, plasticizers, polymeric single-use-systems, risk assessment model, Single-Use Components, slip agents, SUS, wetting agents
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
